市場調査レポート

中国のジェネリック医薬品市場の詳細調査および投資予測

Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016

発行 Huidian Research 商品コード 254654
出版日 ページ情報 英文 70 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
中国のジェネリック医薬品市場の詳細調査および投資予測 Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016
出版日: 2012年08月16日 ページ情報: 英文 70 Pages
概要

中国ではこれまでに10,000種以上のジェネリック医薬品が発売されており、医薬品消費市場において多くのシェアを占めています。医薬品の種類はますます増加し、品質もますます改善されています。中国のジェネリック医薬品はほとんどの一般的な疾患の治療ニーズを満たしており、市場シェアは85%を超えています。中国では医療費が大きな費用となっており、高額な新薬は伸び悩みに直面しています。

当レポートでは、中国のジェネリック医薬品市場の現状と見通しについて調査分析し、中国のジェネリック医薬品の発展の経緯、中国市場の背景・経済環境・関連政策・法規制、需要および消費動向、価格動向、輸出入動向、製造規模および販売収益の予測、市場影響因子の分析、投資機会と投資リスクの分析、主要企業のプロファイルなどをまとめ、概略下記の構成でお届けいたします。

第1章 中国のジェネリック医薬品:概要

  • 定義・特徴・用途
  • 発展の経緯

第2章 海外のジェネリック医薬品市場

  • 概要
  • 世界の販売市場の分布:国別
  • 高い産業統合レベル:競合の激化

第3章 中国のジェネリック医薬品市場を取り巻く環境

  • 中国経済の発展
    • GDPの分析
    • 固定資産投資の分析
    • 都市部・農村部の住人の所得
    • マクロ経済の発展予測
  • 関連政策・規格・法規制

第4章 ジェネリック医薬品市場の特徴

  • 産業統合レベルの分析・予測
  • SWOT分析
  • 参入・撤退状況
  • 代替品

第5章 中国のジェネリック医薬品の発展

  • 中国のジェネリック医薬品の現状と予測
    • 市場の発展状況
    • ジェネリック医薬品企業の地域分布
    • 中国のジェネリック医薬品市場における新規戦略を積極的に調整する主な多国籍企業
  • 市場経路の概要
  • 市場需要
    • 需要の特徴
    • 消費動向の地域的特徴
  • 価格動向
    • 現在の市場価格
    • 市場価格への影響因子
    • 価格動向予測
  • プロモーションの基本的特徴

第6章 中国のジェネリック医薬品の輸出入

  • 医薬品輸出入の成長速度の拡大:貿易収支の改善
  • 欧州・米国市場における成長速度の減速と新興市場の成長速度の加速
  • 特殊バルク薬・西洋の医薬品の輸出の急速な成長
  • バルク薬の輸出の継続的成長・世界市場におけるシェアの拡大
  • 漢方製剤の輸出:EUへの輸出量は減少し始める

第7章 中国のジェネリック医薬品の技術的発展

  • 発展の現状
  • 技術的成熟度
  • 中国と諸外国の技術的ギャップとその理由

第8章 主要企業・競合環境

  • Harbin Pharmaceutical Group Holding Co., Ltd.
  • China Resources Double-crane Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group
  • Tasly Group
  • Livzon Pharmaceutical Group Inc.
  • Qianjin Pharmacy

第9章 ケーススタディ:Shuzhong Pharmacy

第10章 投資環境とリスク

第11章 将来の発展予測・投資見通し

  • 産業の発展動向予測
  • 操業状況の予測
    • 総製造規模の予測
    • 販売収益の予測

第12章 業界の専門家からの投資に関する提言

  • ジェネリック医薬品企業のマーケティングプロモーション戦略
  • ジェネリック医薬品市場の機会推進戦略
目次

This report is currently available in Chinese language only. However, we can provide an English version of the report within 2 days upon orders.

By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market. There are more and more drug varieties and the quality becomes better and better. China's generic drugs can meet the treatment needs of most common diseases and the market share has accounted for more than 85%, at the same time, the health care costs become a large expense in China, the expensive new drugs are facing the growth resistance.

As for the competitive landscape of generic drug sales in different regions, in the advantaged areas such as Beijing, Shanghai, Guangzhou and some other first-tier cities, the foreign investment enterprises and joint ventures occupy an absolute advantage; the annual sales amount of a multinational enterprise in Shanghai Ruijin Hospital reached more than CNY 100 million, this number equivalent to the annual sales level of a medium-sized domestic pharmaceutical enterprise.

In the second-tier cities such as Nanjing, Wuhan and Hangzhou, the domestic brand enterprises formed a strong competitive position, such as Yangtze River Pharmaceutical Group, Harbin Pharmaceutical Group Holding Co., Ltd, Sanjiu Medical & Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd and so on.

In the market of third-tier or four-tier market, especially the rural area markets of counties, villages and towns are flooded with numerous small brands and there is no leading brand in these markets. This means that there are huge opportunities in these markets. If the per capita consumption of drugs in rural market is CNY 120 / year, the rural population in China is nearly 900 million; the market capacity will be CNY 108 billion / year, which means that there are huge opportunities in rural market for generic drugs.

Table of Contents

1. Overview of China's Generic Drug Product

  • 1.1. Definition, Property and Application Characteristics
  • 1.2. Development History
    • 1.2.1. The First Stage: Old Generic Drug
    • 1.2.2. The Second Stage: New Generic Drug
    • 1.2.3. The Third Stage: Large Generic Drug

2. Generic Drug in Overseas Market

  • 2.1. Overview
  • 2.2. The Distribution of Global Marketing Market Sorted by Country
  • 2.3. The Industrial Concentration is High; Competition becomes More and More Fierce

3. Circumstance of China's Generic Drug

  • 3.1. Development of China's Economic
    • 3.1.1. Analysis of GDP
    • 3.1.2. Analysis of Fixed Assets Investment
    • 3.1.3. Analysis of Income of Urban and Rural Residents
    • 3.1.4. Forecast of Macro Economic Development in China
  • 3.2. Relevant Industrial Policies, Standards and Laws and Regulations

4. Characteristic of Generic Drug

  • 4.1. Analysis and Forecast of Market Concentration Grade
  • 4.2. Analysis of SWOT
    • 4.2.1. Strength
    • 4.2.2. Weakness
    • 4.2.3. Opportunity
    • 4.2.4. Threat
  • 4.3. Enter and Exit Status
  • 4.4. Substitutes

5. Development of China's Generic Drug

  • 5.1. Status Quo and Forecast of China's Generic Drug
    • 5.1.1. Market Development Status Quo
    • 5.1.2. Main Distribution Area of Generic Drug Enterprises
    • 5.1.3. Major Multinational Pharmaceutical Enterprises Actively Adjust the New Strategies in China's Generic Drug Market
  • 5.2. Overview of Market Channels
  • 5.3. Market Demand of China's Generic Drug
    • 5.3.1. Demand Characteristics
    • 5.3.2. Consumption Regional Characteristics
  • 5.4. Price Trend of China's Generic Drug
    • 5.4.1. Current Market Price
    • 5.4.2. Factors Affecting Market Price
    • 5.4.3. Forecast of Price Trend
  • 5.5. Basic Characteristic of Promotion
    • 5.5.1. The Recognition is Mature and Have no Necessary to Educate and Promote
    • 5.5.2. The Market is Mature and Have a Huge Market Basis
    • 5.5.3. Price is Mature; the Operational Space is Relatively Small
    • 5.5.4. Channel is Mature and the Channel is willing to Operate
    • 5.5.5. The Categories are too Much, Homogenization Competition is Serious
    • 5.5.6. The Price is Too Transparent
    • 5.5.7. The Approaches are Excessive, Promoting Methods are Similar
    • 5.5.8. Channels Have the Initiative in Hands

6. Import and Export of China's Generic Drug

  • 6.1. Growth Speed of Import and Export of Medicine Increased, the Trade Balance Continued to Improve
  • 6.2. The Growth Speed in European and American Markets Slowed Down; the Growth Speed in the Emerging Markets is Rapid
  • 6.3. The Export of Special Bulk Drugs and Western Medicine Increases Rapidly
  • 6.4. The Export of Bulk Drugs Continues to Increase, the Market Share in Global Market Further Improves
  • 6.5. The Export of Prepared Chinese Medicine is Rebound, the Export Volume to EU Started to Decline

7. Technical Development of China's Generic Drug

  • 7.1. Development Status Quo
  • 7.2. Technical Maturity Grade
  • 7.3. Technical Gap between China and Foreign Countries and the Reasons

8. Main Competitors and Competitive Structure in China

  • 8.1. Harbin Pharmaceutical Group Holding Co., Ltd.
  • 8.2. China Resources Double-crane Pharmaceutical Co., Ltd.
  • 8.3. Yunnan Baiyao Group
  • 8.4. Tasly Group
  • 8.5. Livzon Pharmaceutical Group Inc.
  • 8.6. Qianjin Pharmacy

9. Case Study-Shuzhong Pharmacy

  • 9.1. Company Profile
  • 9.2. Low Price Leads to the Cheating on Workmanship and Materials
  • 9.3. Low Price Bid Inviting Mechanism needs the Further Improvement

10. Investment Environment and Risks

  • 10.1. Investment Environment
  • 10.2. Investment Risk

11. Future Development Forecast and Investment Prediction of Generic Drug in China

  • 11.1. Forecast of Industrial Development Trend
  • 11.2. Forecast of Industrial Operation Situation from 2012 to 2016
    • 11.2.1. Forecast of Gross Industrial Output Value from 2012 to 2016
    • 11.2.2. Forecast of Industrial Sales Revenue from 2012 to 2016

12. Investment Suggestions from Industrial Experts

  • 12.1. Marketing Promotion Strategies of Generic Drug Enterprises
    • 12.1.1. Planning the Marketing Path Based on Company Resource
    • 12.1.2. Apply Key Strategies and Choose Key Cities Based on Competitive Advantages and Market Situation
    • 12.1.3. Take Use of the Method of "Manage after Opening" to Manage and Encourage the Working Team
    • 12.1.4. Flexible Use All Kinds of Terminal Sales Promotion Methods Based on Company Resource
    • 12.1.5. Developed Cautiously Based on the Product Characteristics and Resources as for Hospitals, Medical Dispensaries and Clinics
  • 12.2. Opportunity Promotion Strategies of Generic Drug Market
Back to Top